TINSEQ4 & FY26May 29, 2026

Tilaknagar Industries Limited

5,404words
2turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
May 29, 2026 To, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai 400001 Scrip Code : 507205 To, National Stock Exchange of India Limited E
68%
26, cementing its position as India’s largest P&A brandy. We have delivered a YoY volume growth of 68% for FY26 on combined business, wherein the ex-IB business has delivered a 14% growth in FY26 vs FY
14%
YoY volume growth of 68% for FY26 on combined business, wherein the ex-IB business has delivered a 14% growth in FY26 vs FY25. Mr. Amit Dahanukar Chairman & Managing Director Happy to share that th
135%
l Meeting Q4 FY26 was the first full quarter of IB operations under TI ownership. Volumes grew by 135% YoY to cross 8 mn cases for the combined business. During the quarter, IB business (ex-Maharashtra
9%
oss 8 mn cases for the combined business. During the quarter, IB business (ex-Maharashtra) grew at 9% in volume terms compared to Q4 FY25. With a large part of manufacturing transition already complet
18%
ain and reap benefits of operating leverage & economies of scale – achieve an EBITDA margin of 16-18% on combined business 3. Focus on efficient capital deployment, disciplined debt management and wor
1.0x
ent, disciplined debt management and working capital investments – reduce Net Debt / EBITDA below 1.0x 4. Ride on the Pan-India distribution strength of Imperial Blue and Mansion House franchises to ex
75%
I wanted to also update on the integration of Imperial Blue business. We have now exited TSMA for ~75% of the IB business, and have now taken over manufacturing operations in these states. The remainin
10 million
ng Agreement 4 Mansion House Hits 10 Mn Cases ✓ Sales Milestone - Mansion House Brandy surpassed 10 million cases in sales in FY26, up from 8.7 million cases in FY25 ✓ Portfolio Strength - Presence across
8.7 million
ses ✓ Sales Milestone - Mansion House Brandy surpassed 10 million cases in sales in FY26, up from 8.7 million cases in FY25 ✓ Portfolio Strength - Presence across multiple price points & product segments
INR 941 crore
hts – Q4 FY26 and FY26 6 2 Y F 4 Q Volumes Revenue1,2 NSR1 EBITDA1,2 PAT 1,2,3 8.0 mn cases INR 941 crore INR 1,177 /case INR 146 crores 134.7% increase YoY 154.0% increase YoY 5.4% increase YoY 1
INR 1,177
nd FY26 6 2 Y F 4 Q Volumes Revenue1,2 NSR1 EBITDA1,2 PAT 1,2,3 8.0 mn cases INR 941 crore INR 1,177 /case INR 146 crores 134.7% increase YoY 154.0% increase YoY 5.4% increase YoY 15.5% margin
Speaking time
Company
1
Investor Relations Advisors
1
Opening remarks
Company
Tilaknagar Industries Ltd. (BSE: 507205 | NSE: TI) Ameya Deshpande Chief Strategy Officer Email: adeshpande@tilind.com
Investor Relations Advisors
CDR India Mr. Siddharth Rangnekar +91 97699 19966 Siddharth@cdr-india.com Siddharth@cdr-india.com Mr. Mitesh Jain +91 96194 44691 mitesh@cdr-india.com mitesh@cdr-india.com "Drink responsibly: The consumption of alcoholic beverages should always be approached responsibly and with awareness. Thank You
← All transcriptsTI stock page →